Variable | No AKI | AKIN 1 | AKIN 2 | AKIN 3 | No AKI info |
---|---|---|---|---|---|
(n = 15,478) | (n = 3,067) | (n = 807) | (n = 588) | (n = 7,496) | |
Age - Mean (SD) | 62.0 (20.3) | 74.2 (16.3) | 76.1 (14.7) | 72.5 (15.7) | 54.2 (21.0) |
Age: 18-39 | 17.1% | 5.1% | 3.6% | 4.4% | 29.0% |
40-59 | 23.7% | 11.3% | 8.9% | 16.0% | 28.3% |
60-79 | 36.9% | 38.2% | 37.3% | 40.7% | 29.5% |
80+ | 22.3% | 45.5% | 50.2% | 39.0% | 13.2% |
Male Sex - % | 45.1% | 52.2% | 45.0% | 49.8% | 45.8% |
Deprivation - Median (IQR) | 17.4 (11.8 27.0) | 17.2 (11.8, 25.8) | 17.3 (11.8, 25.8) | 17.2 (11.9, 26.9) | 17.2 (11.7, 26.7) |
AIDS - % | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% |
Malignancy - % | 6.2% | 11.5% | 14.0% | 16.7% | 4.8% |
CHF - % | 2.6% | 10.4% | 13.9% | 11.6% | 1.0% |
CPD - % | 12.8% | 17.0% | 16.1% | 17.4% | 8.5% |
Cerebrovascular disease - % | 7.3% | 13.5% | 12.3% | 11.2% | 3.4% |
Dementia - % | 3.2% | 6.7% | 8.2% | 7.0% | 1.9% |
Diabetes - % | 10.3% | 20.2% | 18.7% | 23.8% | 6.0% |
Hemiplegia. - % | 1.3% | 1.8% | 1.4% | 1.5% | 0.5% |
Hypertension - % | 27.2% | 39.% | 39.3% | 39.0% | 15.5% |
MI - % | 3.0% | 5.0% | 6.0% | 3.9% | 0.7% |
Solid tumour - % | 2.0% | 3.2% | 4.8% | 4.4% | 0.9% |
Liver disease - % | 0.9% | 1.8% | 3.0% | 6.1% | 0.5% |
PVD - % | 2.1% | 5.4% | 6.2% | 4.6% | 1.0% |
Peptic ulcer - % | 0.6% | 1.2% | 1.7% | 1.9% | 0.4% |
Renal disease - % | 1.7% | 11.2% | 16.4% | 22.3% | 1.1% |
Rheumatic disease - % | 2.3% | 3.9% | 3.1% | 4.1% | 1.1% |
CKD - no data | 0% | 0% | 0% | 0.7% | 34.4% |
no CKD | 84.8% | 61.9% | 62.1% | 68.2% | 58.0% |
CKD stage 3a | 10.0% | 19.1% | 20.1% | 15.0% | 5.0% |
CKD stage 3b | 4.0% | 13.1% | 12.1% | 10.2% | 2.0% |
CKD stage 4 | 1.0% | 5.3% | 5.5% | 2.6% | 0.5% |
CKD stage 5 | 0.2% | 0.5% | 0.2% | 3.4% | 0.1% |
Charlson ≤ 0 - % | 58.0% | 31.9% | 25.8% | 23.3% | 74.5% |
1-10 - % | 25.9% | 29.4% | 30.5% | 30.1% | 17.4% |
11 + =% | 16.2% | 38.8% | 43.7% | 46.6% | 8.2% |